BG31496A3 - Method for obtaining of 4- amino- 5- alkyl- sulphonyl ortoanizamid - Google Patents

Method for obtaining of 4- amino- 5- alkyl- sulphonyl ortoanizamid

Info

Publication number
BG31496A3
BG31496A3 BG7942018A BG4201879A BG31496A3 BG 31496 A3 BG31496 A3 BG 31496A3 BG 7942018 A BG7942018 A BG 7942018A BG 4201879 A BG4201879 A BG 4201879A BG 31496 A3 BG31496 A3 BG 31496A3
Authority
BG
Bulgaria
Prior art keywords
ortoanizamid
sulphonyl
amino
alkyl
obtaining
Prior art date
Application number
BG7942018A
Other languages
Bulgarian (bg)
English (en)
Inventor
Thominer
Acher
Monier
Original Assignee
Societe D'etudes Scientifigues Et Industrielles De L'ilede- France,Fr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe D'etudes Scientifigues Et Industrielles De L'ilede- France,Fr filed Critical Societe D'etudes Scientifigues Et Industrielles De L'ilede- France,Fr
Publication of BG31496A3 publication Critical patent/BG31496A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
BG7942018A 1978-01-20 1979-01-10 Method for obtaining of 4- amino- 5- alkyl- sulphonyl ortoanizamid BG31496A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7801632A FR2415099A1 (fr) 1978-01-20 1978-01-20 Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes

Publications (1)

Publication Number Publication Date
BG31496A3 true BG31496A3 (en) 1982-01-15

Family

ID=9203689

Family Applications (2)

Application Number Title Priority Date Filing Date
BG7942018A BG31496A3 (en) 1978-01-20 1979-01-10 Method for obtaining of 4- amino- 5- alkyl- sulphonyl ortoanizamid
BG7943588A BG31497A3 (en) 1978-01-20 1979-01-10 Method for obtaining of 4- amino- 5- alkyl- sulphonyl ortoanizamid

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG7943588A BG31497A3 (en) 1978-01-20 1979-01-10 Method for obtaining of 4- amino- 5- alkyl- sulphonyl ortoanizamid

Country Status (42)

Country Link
US (2) US4294828A (da)
JP (1) JPS6049192B2 (da)
AR (2) AR221354A1 (da)
AT (1) AT377977B (da)
AU (1) AU528561B2 (da)
BE (1) BE872585A (da)
BG (2) BG31496A3 (da)
CA (1) CA1101430A (da)
CH (1) CH637927A5 (da)
CS (1) CS226181B2 (da)
CY (1) CY1201A (da)
DD (1) DD141520A5 (da)
DE (1) DE2901181C2 (da)
DK (1) DK158346C (da)
EG (1) EG14045A (da)
ES (2) ES476755A1 (da)
FI (1) FI71126C (da)
FR (1) FR2415099A1 (da)
GB (2) GB2012765B (da)
GR (1) GR64431B (da)
HK (1) HK12184A (da)
HU (1) HU179793B (da)
IE (1) IE47798B1 (da)
IL (1) IL56411A (da)
IN (1) IN150226B (da)
IT (1) IT1164655B (da)
LU (1) LU80786A1 (da)
MC (1) MC1232A1 (da)
MX (2) MX5793E (da)
NL (1) NL191707C (da)
NO (1) NO151320C (da)
NZ (1) NZ189378A (da)
OA (1) OA06156A (da)
PH (2) PH15725A (da)
PL (2) PL116532B1 (da)
PT (1) PT69068A (da)
RO (2) RO80311A (da)
SE (2) SE448874B (da)
SU (1) SU820659A3 (da)
YU (2) YU42172B (da)
ZA (1) ZA79219B (da)
ZM (1) ZM579A1 (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2440946A2 (fr) * 1978-01-20 1980-06-06 Ile De France Nouveaux benzamides heterocycliques substitues, leurs procedes de preparation et leur application comme modificateurs du comportement
NZ199080A (en) * 1980-12-12 1984-07-31 Beecham Group Ltd 2-alkoxy-4-amino-5-alkylsulphonyl-n-(3beta-(8-hydrocarbyl-8-azabicyclo (3,2,1)octyl))benzamides
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2574795B1 (fr) * 1984-12-18 1987-11-20 Ile De France Nouveau procede industriel de synthese du n-((1'-allyl 2'-pyrrolidinyl) methyl) 2-methoxy 4,5-azimido benzamide
FR2584401B1 (fr) * 1985-07-04 1987-11-20 Ile De France Nouveau benzamide, son procede de preparation et son application dans le domaine therapeutique
US5260319A (en) * 1989-12-26 1993-11-09 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
US5227388A (en) * 1989-12-26 1993-07-13 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
FR2678266A1 (fr) * 1991-06-28 1992-12-31 Delagrange Laboratoires Nouveaux derives de 2-hydroxy 4-amino 5-ethylsulfonyl benzamide utiles comme anxiolytiques.
FR2699533A1 (fr) * 1992-12-21 1994-06-24 Mouhtaram Mohamed Dérivés de N-((1,4-dialkyl-6-arylpipérazine-2-yl)méthyl)benzamides. (Isomères cis et trans) Propriétés pharmacologiques et applications.
FR2753376B1 (fr) * 1996-09-18 1998-10-16 Synthelabo Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques
FR2762213B1 (fr) * 1997-04-18 1999-05-14 Synthelabo Composition pharmaceutique a retention gastrique
US6169094B1 (en) 1998-07-14 2001-01-02 Sanofi-Synthelabo Compositions of (S) (-)-amisulpride
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
CA2525366A1 (en) * 2003-05-16 2004-11-25 Pfizer Products Inc. Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
EP1753460A2 (en) * 2004-05-11 2007-02-21 Pfizer Products Inc. Combination of atypical antipsychotics and 5-ht1b receptor antagonists
WO2006116221A2 (en) * 2005-04-22 2006-11-02 Wyeth Therapeutic combinations for the treatment or prevention of psychotic disorders
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
US7825156B2 (en) * 2007-02-02 2010-11-02 Copharms Method of treating bipolar depression with a benzamide derivative
JP2011526881A (ja) * 2008-06-25 2011-10-20 ファイザー・インク ジアリール化合物およびそれらの使用
US20100105755A1 (en) * 2008-09-12 2010-04-29 Auspex Pharmaceuticals, Inc. Substituted benzamide modulators of dopamine receptor
PT3395372T (pt) 2009-02-20 2022-05-05 Enhanx Biopharm Inc Sistema de entrega de medicamentos à base de glutationa
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
CN101898991B (zh) * 2009-05-31 2013-09-25 江苏天士力帝益药业有限公司 一种(s)(-)-氨磺必利d-(-)-酒石酸盐的合成方法
CN101628886B (zh) * 2009-08-25 2012-12-12 北京紫萌同达科技有限公司 一种2-甲氧基-4-氨基-5-乙砜基苯甲酸的合成方法
GB201004020D0 (en) * 2010-03-11 2010-04-21 Acacia Pharma Ltd New therapeutic use
AU2016216578B2 (en) * 2010-03-11 2017-11-23 Acacia Pharma Limited The use of amisulpride as an anti-emetic
AU2014202535B2 (en) * 2010-03-11 2016-05-26 Acacia Pharma Limited The use of amisulpride as an anti-emetic
EP2582665A1 (en) 2010-06-17 2013-04-24 Lupin Limited An improved process for preparation of amisulpride
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN103304453A (zh) * 2013-06-18 2013-09-18 苏州诚和医药化学有限公司 两步法合成2-甲氧基-4-氨基-5-乙砜基苯甲酸
CN103319384A (zh) * 2013-06-18 2013-09-25 苏州诚和医药化学有限公司 制备2-甲氧基-4-氨基-5-乙砜基苯甲酸的方法
CN103450058B (zh) * 2013-09-18 2015-10-14 广安凯特医药化工有限公司 一种氨磺必利酸的制备方法
CN104725292B (zh) * 2015-03-23 2017-07-25 湖北荆江源制药股份有限公司 一种(s)(‑)‑氨磺必利的制备方法
GB201618425D0 (en) * 2016-11-01 2016-12-14 Acacia Pharma Ltd method
SG10201914135TA (en) 2016-11-28 2020-02-27 Lb Pharmaceuticals Inc Psychotropic agents and uses thereof
US11377421B2 (en) 2016-11-28 2022-07-05 Lb Pharmaceuticals Inc. Psychotropic agents and uses thereof
CN106995397B (zh) * 2016-12-12 2020-01-14 河北医科大学 R-氨磺必利药用盐、制备方法、晶型及其用途
GB201702250D0 (en) 2017-02-10 2017-03-29 Acacia Pharma Ltd Method
MX2020005518A (es) 2017-12-05 2020-11-06 Sunovion Pharmaceuticals Inc Mezclas no racemicas y usos de las mismas.
CA3088356A1 (en) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Crystal forms and production methods thereof
CN110790693A (zh) * 2018-08-02 2020-02-14 北京万全德众医药生物技术有限公司 一种(s)(-)-氨磺必利的制备方法
AU2020286441A1 (en) 2019-06-04 2022-01-06 Sunovion Pharmaceuticals Inc. Modified release formulations and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR2313935A1 (fr) * 1975-06-10 1977-01-07 Ile De France Nouveaux benzamides substitues, leurs derives et leur procede de preparation
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
FR2244760B1 (da) * 1973-09-25 1980-06-27 Ile De France
FR2299862B1 (fr) * 1975-02-07 1978-07-21 Ile De France Nouveau
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
IE42210B1 (en) * 1974-12-18 1980-06-18 Synthelabo 2-methoxy-benzamide derivatives

Also Published As

Publication number Publication date
IL56411A0 (en) 1979-03-12
YU42172B (en) 1988-06-30
NO151320C (no) 1985-04-17
IT7947706A0 (it) 1979-01-18
DK158346C (da) 1990-10-08
BG31497A3 (en) 1982-01-15
NL191707B (nl) 1995-12-01
OA06156A (fr) 1981-06-30
AR220574A1 (es) 1980-11-14
IL56411A (en) 1982-09-30
PL118151B1 (en) 1981-09-30
JPS54145658A (en) 1979-11-14
US4401822A (en) 1983-08-30
GB2012765B (en) 1982-09-08
BE872585A (fr) 1979-06-07
US4294828A (en) 1981-10-13
AU4337379A (en) 1979-07-26
SU820659A3 (ru) 1981-04-07
IE790092L (en) 1979-07-20
RO80311A (ro) 1982-12-06
GB2083458A (en) 1982-03-24
NZ189378A (en) 1983-03-15
CS226181B2 (en) 1984-03-19
NL7900457A (nl) 1979-07-24
FI790182A (fi) 1979-07-21
SE7900380L (sv) 1979-07-21
PT69068A (fr) 1979-02-01
AR221354A1 (es) 1981-01-30
DK158346B (da) 1990-05-07
NL191707C (nl) 1996-04-02
NO151320B (no) 1984-12-10
GB2012765A (en) 1979-08-01
IT1164655B (it) 1987-04-15
FR2415099B1 (da) 1981-02-20
EG14045A (en) 1983-09-30
FR2415099A1 (fr) 1979-08-17
SE8603773D0 (sv) 1986-09-09
DD141520A5 (de) 1980-05-07
MC1232A1 (fr) 1979-10-26
PL116532B1 (en) 1981-06-30
AT377977B (de) 1985-05-28
HU179793B (en) 1982-12-28
SE460968B (sv) 1989-12-11
YU5079A (en) 1983-06-30
FI71126C (fi) 1986-11-24
IN150226B (da) 1982-08-21
IE47798B1 (en) 1984-06-27
YU25483A (en) 1983-10-31
SE448874B (sv) 1987-03-23
GR64431B (en) 1980-03-21
DK20979A (da) 1979-07-21
DE2901181C2 (de) 1984-07-19
GB2083458B (en) 1983-03-09
ES477782A1 (es) 1979-09-16
NO790180L (no) 1979-07-23
ZM579A1 (en) 1979-12-21
MX7623E (es) 1990-03-27
MX5793E (es) 1984-07-19
CH637927A5 (fr) 1983-08-31
DE2901181A1 (de) 1979-07-26
ES476755A1 (es) 1979-06-01
HK12184A (en) 1984-02-24
ZA79219B (en) 1980-01-30
JPS6049192B2 (ja) 1985-10-31
CA1101430A (en) 1981-05-19
SE8603773L (sv) 1986-09-09
YU41278B (en) 1986-12-31
PH15725A (en) 1983-03-18
PH22287A (en) 1988-07-22
PL212899A1 (da) 1980-01-14
ATA39879A (de) 1983-12-15
AU528561B2 (en) 1983-05-05
LU80786A1 (fr) 1979-09-07
CY1201A (en) 1983-12-31
RO76393A (ro) 1981-03-30
FI71126B (fi) 1986-08-14

Similar Documents

Publication Publication Date Title
BG31496A3 (en) Method for obtaining of 4- amino- 5- alkyl- sulphonyl ortoanizamid
BG31646A3 (en) Method for obtaining of phenethanolamina
BG32115A4 (en) Method for obtaining of midantion
BG31493A3 (en) Method for obtaining of phenetanolamines
JPS5558521A (en) Method of moving
BG48931A3 (en) Method for preparing of pyretroids
IL56906A0 (en) Method of preparing trifluoromethylphenols
DK153480A (da) Simulator-moduler og rack-opbygning
BG33295A3 (en) Method for obtaining of vindezine
DE2960121D1 (en) Method of preparing monoarylthiourea
BG33285A3 (en) Method for obtaining of benzocyclopheptapyran
BG27797A1 (en) Method of obtaining of kermet for magnetic-abrasive poliching
BG32192A1 (en) Method for obtaining of glucoseisomerase
SU1086717A1 (ru) Способ получения п-изопропоксибензальдегида
JPS54156692A (en) Method of measuring saccharoid
BG27777A1 (en) Method of obtaining of diatetic product- yoghourt
PL110299B2 (en) Method of obtaining 2-methoxy-4-chloro-phenol
BG27949A1 (en) Method of obtaining of 2-azetidinons
JPS54120031A (en) Method of making case
JPS54120032A (en) Method of making case
BG31228A3 (en) Method for obtaining of 2- metil- 2- xjdroxjpropjl piperazine- 1- carboxjate derivatives
JPS54106577A (en) Method of making stereopatterm
BG32193A1 (en) Method for obtaining of glucoseisomerase
BG32614A1 (en) Method for obtaining of foamglass
BG29772A1 (en) Method for obtaining of dimitrates